EP1150684A4 - Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts - Google Patents

Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts

Info

Publication number
EP1150684A4
EP1150684A4 EP00911738A EP00911738A EP1150684A4 EP 1150684 A4 EP1150684 A4 EP 1150684A4 EP 00911738 A EP00911738 A EP 00911738A EP 00911738 A EP00911738 A EP 00911738A EP 1150684 A4 EP1150684 A4 EP 1150684A4
Authority
EP
European Patent Office
Prior art keywords
bone
autografic
allogeneic
xenografic
resorptive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00911738A
Other languages
German (de)
French (fr)
Other versions
EP1150684A1 (en
Inventor
John H Healey
Gene R Diresta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of EP1150684A1 publication Critical patent/EP1150684A1/en
Publication of EP1150684A4 publication Critical patent/EP1150684A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/112—Phosphorus-containing compounds, e.g. phosphates, phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00911738A 1999-02-09 2000-02-09 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts Withdrawn EP1150684A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11926099P 1999-02-09 1999-02-09
US119260P 1999-02-09
PCT/US2000/003285 WO2000047214A1 (en) 1999-02-09 2000-02-09 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts

Publications (2)

Publication Number Publication Date
EP1150684A1 EP1150684A1 (en) 2001-11-07
EP1150684A4 true EP1150684A4 (en) 2005-06-15

Family

ID=22383420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00911738A Withdrawn EP1150684A4 (en) 1999-02-09 2000-02-09 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts

Country Status (5)

Country Link
EP (1) EP1150684A4 (en)
JP (1) JP2002536123A (en)
AU (1) AU776555B2 (en)
CA (1) CA2360319A1 (en)
WO (1) WO2000047214A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632447B1 (en) 1998-05-07 2003-10-14 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6413535B1 (en) 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
JP2004526747A (en) * 2001-04-03 2004-09-02 ザ ロイヤル アレクサンドラ ホスピタル フォー チルドレン Drugs used in bone transplantation
CA2468581A1 (en) * 2001-11-29 2003-06-05 Kathy Rzeszutek Resorption-controlled bone implants
FR2836681B1 (en) 2002-03-04 2004-06-18 Centre Nat Rech Scient MODIFIED PHOSPHOCALCIC COMPOUND, INJECTION COMPOSITION CONTAINING THE SAME
IL153699A (en) 2002-12-26 2008-11-26 Prochon Biotech Ltd Bone graft composite
GB0307834D0 (en) * 2003-04-04 2003-05-14 Ta Contrast Ab Composition
EP1691614B1 (en) * 2003-12-04 2013-02-13 University Of Iowa Research Foundation Gallium inhibits biofilm formation
JP5167538B2 (en) * 2005-05-16 2013-03-21 国立大学法人 東京医科歯科大学 Bone cement and dental prosthesis
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP1958649A1 (en) * 2007-02-14 2008-08-20 Graftys Injectable calcium-phosphate cement releasing a bone resorption inhibitor
WO2009006921A1 (en) * 2007-07-10 2009-01-15 Barrera Jose Bouza Microporous material for surgical implant
WO2009134856A2 (en) * 2008-04-30 2009-11-05 Genta Incorporated Pharmaceutical gallium compositions and methods
EP2228080A1 (en) * 2009-03-03 2010-09-15 Graftys Galliated calcium phosphate biomaterials
US20140248372A1 (en) 2011-09-19 2014-09-04 Emory University Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
DE102016209988A1 (en) * 2016-06-07 2017-12-07 Heraeus Medical Gmbh Paste-like two-component polymethyl methacrylate bone cement
CN109010909A (en) * 2018-09-05 2018-12-18 杭州市萧山区中医院 The compound erythromycin bone cement of polymethyl methacrylate is used to prevent and treat the application of Periprosthetic bone dissolution and inflammatory reaction
CN109010334A (en) * 2018-09-05 2018-12-18 杭州市萧山区中医院 The compound Simvastatin bone cement of polymethyl methacrylate is used to prepare the application in the drug of the dissolution of Periprosthetic bone and inflammatory reaction
CN111321403B (en) * 2020-03-10 2022-03-11 河北北方学院 Preparation method of dopamine-based zinc surface gallium-loaded graphene oxide composite coating
CN113181425A (en) * 2021-04-28 2021-07-30 北京邦塞科技有限公司 Bone cement solid-phase powder, bone cement and preparation method and application thereof
CN114984310B (en) * 2022-06-30 2023-09-08 西安理工大学 Organic-inorganic composite bone cement capable of resisting collapse, absorbing water and expanding and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039107A1 (en) * 1995-06-06 1996-12-12 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92465C (en) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen A method for handling endo-osteal materials
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
MXPA97009909A (en) * 1995-06-06 2004-08-23 Gensci Regeneration Lab Inc Modified osteogenic materials.
US6010711A (en) * 1996-01-26 2000-01-04 University Of Rochester Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039107A1 (en) * 1995-06-06 1996-12-12 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0047214A1 *

Also Published As

Publication number Publication date
AU776555B2 (en) 2004-09-16
JP2002536123A (en) 2002-10-29
CA2360319A1 (en) 2000-08-17
WO2000047214A1 (en) 2000-08-17
AU3358800A (en) 2000-08-29
EP1150684A1 (en) 2001-11-07
WO2000047214A9 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
EP1150684A4 (en) Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
EP1180000A4 (en) Prosthetic grafts
AU2001259154A1 (en) Bone fixation system
DE69929513D1 (en) bone prosthesis
GB0014079D0 (en) Orthopaedic implant
HUP0200409A3 (en) Valdecoxib compositions, process for their preparation and their use
HK1062999A1 (en) Bone fixation system.
AU2001255846A8 (en) Dental implant system
AU7994300A (en) Nell-1 enhanced bone mineralization
GB0027542D0 (en) Silicone cosmesis
GB9920785D0 (en) Bone splint
GB9812103D0 (en) Surgical implant
AU1854401A (en) Bone implant
GB9926231D0 (en) Medical implants
MXPA02001613A (en) Tissue augmentation material and methods.
GB9924959D0 (en) Implant alignment
GB9928837D0 (en) Novel bone cement
AU2002321019A1 (en) Bone implant
GB9910377D0 (en) Tissue engineering
GB2347865B (en) Cotyloid prosthesis
HUP0004776A3 (en) Prosthesis system
PL349786A1 (en) Bone stimulating factor
EP1194439A4 (en) Human eag2
GB0130539D0 (en) Bone marrow-specific protein
AU137971S (en) Implant

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010831

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RBV Designated contracting states (corrected)

Designated state(s): DE FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 20050425

17Q First examination report despatched

Effective date: 20060224

17Q First examination report despatched

Effective date: 20060224

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081126